Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2014

Schedule of Segment Reporting Information, by Segment

The following tables present revenues, gross profit, operating income and amortization by reportable segment for the three months ended March 31, 2014 and 2013 (in thousands):



2014:	Apex		Oxford		Physician		Life Sciences Europe		Corporate			Total
Revenues	$	278,408	$	117,500	$	31,791	$	11,575	$	—		$	439,274
Gross profit	75,506		49,026		8,838		4,218		—			137,588
Operating income	22,784		14,284		1,259		1,199		(12,244		)	27,282
Amortization	4,089		1,370		634		71		8			6,172



2013:	Apex		Oxford		Physician		Life Sciences Europe		Corporate			Total
Revenues	$	239,765	$	102,688	$	26,302	$	10,289	$	—		$	379,044
Gross profit	63,981		34,815		7,483		3,832		—			110,111
Operating income	17,229		13,666		2,426		533		(10,999		)	22,855
Amortization	4,881		107		176		160		55			5,379

Schedule of Revenue by Geographical Areas

The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents domestic and foreign revenues (in thousands):



	Three Months Ended
	March 31,
	2014		2013
Revenues:
Domestic	$	418,664	$	358,648
Foreign	20,610		20,396
	$	439,274	$	379,044

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details